Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2024 earnings outcomes as we speak.

Reported gross sales elevated 5.3% year-over-year to $22.5 billion. Operational gross sales development was 6.7%.

Internet earnings decreased 17% to $3.4 billion, or $1.41 per share, in comparison with final 12 months. Adjusted EPS decreased 10.9% to $2.04.

Income surpassed projections whereas earnings got here in keeping with estimates.

For full-year 2025, the corporate expects reported gross sales of $89.2-90.0 billion and adjusted EPS of $10.50-10.70.

The inventory stayed purple in premarket hours on Wednesday.

Prior efficiency